Carlsmed (CARL) Gains from Investment Securities (2024 - 2025)

Carlsmed (CARL) posted Gains from Investment Securities of -$7000.0 for Q4 2025, down 110.77% on a QoQ basis from $65000.0 in Q3 2025, and down 112.73% year-over-year from $55000.0 in Q4 2024.

Carlsmed (CARL) Gains from Investment Securities (2024 - 2025) Analysis & Trends

Carlsmed's Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$7000.0 for Q4 2025.

  • Quarterly Gains from Investment Securities fell 112.73% year-over-year to -$7000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $295000.0 (up 66.67% YoY) and the FY2025 annual result came in at $328000.0, up 127.78% from the prior year.
  • Gains from Investment Securities was -$7000.0 for Q4 2025 at Carlsmed, down from $65000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $237000.0 in Q2 2025 and bottomed at -$7000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.68 Bn -
10 Carlsmed 307.54 Mn 234.42 Mn 12.43 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -7,000.00
Dec 31, 2025 -7,000.00
Sep 30, 2025 65,000.00
Sep 30, 2025 65,000.00
Jun 30, 2025 237,000.00
Jun 30, 2025 237,000.00
Mar 31, 2025 33,000.00
Mar 31, 2025 33,000.00
Dec 31, 2024 55,000.00
Dec 31, 2024 55,000.00
Sep 30, 2024 28,000.00
Sep 30, 2024 28,000.00
Jun 30, 2024 61,000.00
Jun 30, 2024 61,000.00